Targeting vivax malaria in the Asia Pacific: The Asia Pacific Malaria Elimination Network Vivax Working Group
Anstey NM., Auburn SA., Kevin BK., Battle KE., Bobogare AB., Chancellor AC., Chasombat SC., Cheng QC., Domingo GJ., Drakeley CJ., Drukpa TD., Dysoley LD., Espino FE., Gething PW., Ghimire PG., Gosling RD., Grewal-Daumerie PGD., Hay SI., Howes RE., Hwang JM., Karim JK., Khan WA., Kim JY., Ley BL., Mannion KM., McCarthy JM., Keong WM., Mueller MI., Namgay RN., Price RN., Qi GQ., Rebueno MR., Reeder JR., Richards JR., Sattabongkot-Prachumsri JSP., Shanks GD., Sibley CH., Surya AS., Taleo GT., Thang ND., Thongpaseuth VT., Thriemer KT., Trimarsanto HT., Vestergaard LS., Seidelein LV., Whittaker MW.
© 2015 World Health Organization; licensee BioMed Central. The Asia Pacific Malaria Elimination Network (APMEN) is a collaboration of 18 country partners committed to eliminating malaria from within their borders. Over the past 5 years, APMEN has helped to build the knowledge, tools and in-country technical expertise required to attain this goal. At its inaugural meeting in Brisbane in 2009, Plasmodium vivax infections were identified across the region as a common threat to this ambitious programme; the APMEN Vivax Working Group was established to tackle specifically this issue. The Working Group developed a four-stage strategy to identify knowledge gaps, build regional consensus on shared priorities, generate evidence and change practice to optimize malaria elimination activities. This case study describes the issues faced and the solutions found in developing this robust strategic partnership between national programmes and research partners within the Working Group. The success of the approach adopted by the group may facilitate similar applications in other regions seeking to deploy evidence-based policy and practice.